|1.||Dubois, Philippe: 4 articles (08/2013 - 01/2011)|
|2.||Raes, Martine: 3 articles (08/2013 - 01/2012)|
|3.||Piel, Géraldine: 2 articles (08/2013 - 02/2012)|
|4.||Piette, Jacques: 2 articles (08/2013 - 02/2012)|
|5.||Shim, Yong-Ho: 2 articles (02/2012 - 01/2011)|
|6.||Van Overstraeten-Schlögel, Nancy: 2 articles (02/2012 - 01/2012)|
|7.||Tevel, Virginie: 2 articles (02/2012 - 01/2012)|
|8.||Stenzel, Martina H: 1 article (07/2015)|
|9.||Wong, Chin Ken: 1 article (07/2015)|
|10.||Jiang, Yanyan: 1 article (07/2015)|
01/01/2012 - "These results suggest that PDMAEMA-based polymers can be efficiently used to transfect immortalized keratinocytes and, thus, open new perspectives in the therapy of skin carcinoma. "
05/01/1999 - "Poly(2-(dimethylamino)ethyl methacrylate) (p(DMAEMA)) can be used successfully for in vitro transfection of different cell lines, including the OVCAR-3 human ovarian carcinoma cell line. "
02/01/2012 - "Together, these results suggest that PDMAEMA-PMEMA copolymers combining low toxicity, vectorization and proton sponge properties, can be efficiently used to transfect immortalized keratinocytes and so open new perspectives in the therapy of skin carcinomas as well as of other skin diseases of genetic or immunological origin."
02/01/2012 - "In this study, we investigated the transfection of immortalized keratinocytes, used as an in vitro model for skin carcinoma, using the antisense technology and poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA)-based copolymers. "
01/01/2012 - "In this study, we investigated the transfection of immortalized keratinocytes, used as an in vitro model for skin carcinoma, using antisense technology and poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA)-based polymers, with original architecture and functionalities. "
08/01/2014 - "In addition, the potential of the PDMAEMA-grafted Au NR carriers to be utilized as a computed tomography contrast agent for the imaging of cancer cells has also been investigated. "
08/01/2013 - "Then the ability of the PDMAEMA-b-PMEMA/Ru-P-4 antisense oligonucleotide polyplexes to transfect two keratinocyte cell lines (SiHa and HaCat) and the capacity of polyplexes to inhibit HPV16+ cervical cancer cell growth was evaluated. "
07/01/2015 - "These result were reflected when investigating the performance of the polyplex using MCF-7 multicellular tumor spheroids, where again the medium PDMAEMA chain length led to the best delivery vehicle for ISIS5132. "
07/01/2015 - "An Oligonucleotide Transfection Vector Based on HSA and PDMAEMA Conjugation: Effect of Polymer Molecular Weight on Cell Proliferation and on Multicellular Tumor Spheroids."
09/13/2010 - "These results suggest that mPEG-b-PCL-b-PDMAEMA NPs may be a promising vector to deliver anticancer drugs and pDNA simultaneously for achieving the synergistic/combined effect on cancer therapies."
08/10/2011 - "No clear correlation has been evidenced between PDMAEMA-induced hemagglutination, PEI-induced hemagglutination, and hemolysis. "
01/01/2011 - "In in vitro hemolysis tests with human red blood cells, AmBincorporated PCL-b-PDMAEMA nanoparticles were seen to be 10 times less cytotoxic than free AmB (5 microgram/ml). "
|5.||Dehydration (Water Stress)
01/17/2012 - "Poly[2-(dimethylamino)ethyl methacrylate] (PDMAEMA) chains are grafted on solid surfaces to investigate the change of interfacial water structure with varying surface charge density induced by tuning the solution pH. At pH ≤ 7.1, SFG-VS intensity is linear to the loss of mass of interfacial water caused by the dehydration of PDMAEMA chains, and no reorientation of the strongly bonded water molecules is observed in the light of χ(ppp)/χ(ssp) ratio. "
08/03/2010 - "In both solutions, the use of a water-soluble PEO outer block helps preventing aggregation of AuNPs upon dehydration (decreased solubility) of either PDMAEMA chains at T > LCST or quaternized PDMAEMA chains at T < UCST. "
|3.||Small Interfering RNA (siRNA)
|4.||DNA (Deoxyribonucleic Acid)
|5.||Connective Tissue Growth Factor
|7.||RNA (Ribonucleic Acid)